Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV‐5500) in PTSD: A randomized, double‐blind, placebo‐controlled trial-Reference-Cited by-同舟云学术

Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV‐5500) in PTSD: A randomized, double‐blind, placebo‐controlled trial

Published:2021-07-12 Issue:11 Volume:38 Page:1108-1119
ISSN:1091-4269
Container-title:Depression and Anxiety
language:en
Short-container-title:Depression and Anxiety

Author:

Ramakrishnan Nithya¹²^ORCID,Lijffijt Marijn¹²,Green Charles E.³,Balderston Nicholas L.⁴,Murphy Nicholas¹²⁵,Grillon Christian⁶,Iqbal Tabish¹²,Vo‐Le Brittany¹²,O'Brien Brittany¹²,Murrough James W.⁷,Swann Alan C.¹²,Mathew Sanjay J.¹²⁵

Affiliation:

1. Menninger Department of Psychiatry & Behavioral Sciences, Mood and Anxiety Disorders Program Baylor College of Medicine Houston Texas USA

2. Michael E. Debakey VA Medical Center Houston Texas USA

3. Department of Pediatrics, McGovern Medical School University of Texas Houston Texas USA

4. Department of Psychiatry University of Pennsylvania School of Medicine Philadelphia Pennsylvania USA

5. The Menninger Clinic Houston Texas USA

6. Intramural Research Program, NIMH Bethesda Maryland USA

7. Department of Psychiatry, Department of Neuroscience, Depression and Anxiety Center for Discovery and Treatment Icahn School of Medicine at Mount Sinai New York New York USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/da.23194

Reference75 articles.

1. The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder

2. Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment‐resistant depression;Albott C. S.;Journal of Clinical Psychiatry,2018

3. Pharmacotherapy for post‐traumatic stress disorder in combat veterans: Focus on antidepressants and atypical antipsychotic agents;Alexander W.;Pharmacy and Therapeutics,2012

4. American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders Fifth Edition. Arlington VA Am Psychiatr Publ2013.

5. Low-frequency parietal repetitive transcranial magnetic stimulation reduces fear and anxiety

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders;Behavioural Brain Research;2024-08

2. Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov;Translational Psychiatry;2024-07-31

3. Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review;Current Neuropharmacology;2024-04

4. (2R,6R)-hydroxynorketamine improves PTSD-associated behaviors and structural plasticity via modulating BDNF-mTOR signaling in the nucleus accumbens;Journal of Affective Disorders;2023-08

5. Replication of distinct trajectories of antidepressant response to intravenous ketamine;Journal of Affective Disorders;2023-01